| Membranous nephropathy in children: clinical presentation and therapeutic approach. | |
| | |
MedLine Citation:
|
PMID: 19908069 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The approach to the pediatric patient with membranous nephropathy (MN) can be challenging to the practitioner. The clinical presentation of the child with this histologic entity usually involves some degree of proteinuria ranging from persistent, subnephrotic-ranged proteinuria to overt nephrotic syndrome. Patients often have accompanying microscopic hematuria and may have azotemia or mild hypertension. Children presenting with nephrotic syndrome are often steroid resistant; as such, their biopsy for steroid-resistant nephrotic syndrome results in the diagnosis of MN. The practitioner treating MN in the pediatric patient must weigh the risks of immunosuppressive therapy against the benefits. In general, the child with subnephrotic proteinuria and normal renal function can likely be treated conservatively with angiotensin blockade (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) without the need for immunosuppressive therapy. Those with nephrotic syndrome are usually treated with steroids initially and often followed by alkylating agents (cyclophosphamide or chlorambucil). Calcineurin inhibitors may also be useful, but the relapse rate after their discontinuation remains high. The absence of controlled studies in children with MN makes treatment recommendations difficult, but until they are available, using the patient's clinical presentation and risk of disease progression appears to be the most prudent approach. |
| | |
Authors:
|
Shina Menon; Rudolph P Valentini |
Related Documents
:
|
2256469 - Ciclosporin in minimal-change glomerulopathy and in focal segmental glomerular sclerosis. 3712479 - Syndromes, communicative disorders, and black children. 18212429 - Late-onset nephrotic syndrome in galloway-mowat syndrome: a case report. 6520839 - Felty's syndrome in a child. 8507929 - Nephrotic syndrome with massive accumulation of type i and type iii collagen in the glo... 19474279 - Congenital disorders of glycosylation: a rare cause of nephrotic syndrome. 2846249 - Turcot's syndrome. a review. 15034579 - A previously unidentified mecp2 open reading frame defines a new protein isoform releva... 19469849 - Familial mesial temporal lobe epilepsies: clinical and genetic features. |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-11-12 |
Journal Detail:
|
Title: Pediatric nephrology (Berlin, Germany) Volume: 25 ISSN: 1432-198X ISO Abbreviation: Pediatr. Nephrol. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-06-18 Completed Date: 2010-10-04 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8708728 Medline TA: Pediatr Nephrol Country: Germany |
Other Details:
|
Languages: eng Pagination: 1419-28 Citation Subset: IM |
Affiliation:
|
The Carman and Ann Adams Department of Pediatrics, Division of Nephrology, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, MI, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
therapeutic use Antihypertensive Agents / therapeutic use Biopsy Child Chlorambucil / therapeutic use Cyclophosphamide / therapeutic use Glomerulonephritis, Membranous / complications, drug therapy* Humans Hypertension / complications, drug therapy Immunosuppressive Agents / therapeutic use Nephrotic Syndrome / complications, drug therapy Proteinuria / complications, drug therapy Steroids / therapeutic use Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 0/Immunosuppressive Agents; 0/Steroids; 305-03-3/Chlorambucil; 50-18-0/Cyclophosphamide |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparative in vitro tests on the efficacy and safety of 13 anti-head-lice products.
Next Document: Membranoproliferative glomerulonephritis.